NextCure, Inc. - Common Stock – Quartals-Cashflow (NASDAQ:NXTC) | MetaTrader

Vollständige Grafik anzeigen Full chart

Financials

Übersicht Finanzbericht Statistik

Vierteljährlich Jährlich

Gesamtvermögen 80.86 M67.14 M47.69 M39.61 M50.18 M37.98 M Gesamtverbindlichkeiten 15.39 M11.28 M16.04 M15.97 M15.24 M11.26 M Gesamtkapital 65.47 M55.85 M29.65 M23.65 M34.94 M26.72 M Gesamtverbindlichkeiten und Eigenkapital 80.86 M67.14 M47.69 M39.61 M50.18 M37.98 M Gesamtverschuldung —————— Nettoverschuldung ——————

Nachrichten

Lucid Capital Markets startet Coverage für NextCure mit Kaufempfehlung – ADC-Pipeline im Fokus

NextCure stellt auf ASCO-Kongress neue Studiendaten zum Krebsmedikament SIM0505 vor

NextCure gibt Update zu ADC-Programmen und meldet Liquiditätsbestand

NextCure provides updates on ADC programs, reports cash position

NextCure secures $21.5 million in private placement to extend cash runway

NextCure raises $21.5 million in private placement to fund ADC programs

Does NextCure (NXTC) Have the Potential to Rally 107.88% as Wall Street Analysts Expect?

Curanex Pharmaceuticals closes $15 million IPO on NASDAQ

NextCure (NXTC) Q2 Loss Widens 71%

NextCure stock soars after positive data for bone disease treatment

Why Deckers Outdoor Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - Absci (NASDAQ:ABSI), AST SpaceMobile (NASDAQ:ASTS)

Piper Sandler lowers NextCure stock price target to $15 after reverse split